WHO Sounds Alert Over Critical Shortage of Obesity Medications
Under 10% of patients that would benefit from obesity jabs like Wegovy have access to them, warns the World Health Organization as it publishes its initial recommendations on the therapies.
Given over a billion individuals worldwide currently classified as obese, it is calling for more widespread and fairer access to these injectable treatments.
According to estimates, in excess of 2,000,000,000 are projected to be living with obesity by 2030 unless action is taken.
"Our new guidance recognises that obesity is a chronic disease that can be treated with thorough and lifelong support," stated WHO director-general Tedros Adhanom Ghebreyesus.
Significant expense, constrained manufacturing, and distribution challenges are key obstacles to widespread availability to the treatments that can aid individuals in losing substantial weight, says the organization.
Skinny Jab Shortage
Even in the present most optimistic outlook, the production of GLP-1 therapies might only reach about 100 million people – under 10% of eligible patients, as stated by the WHO.
The guideline calls on nations and manufacturers to increase access, through approaches like licensing agreements.
A patent on a key compound – the core ingredient of a leading brand – is scheduled to end in a number of countries in 2026.
How Weight-Loss Drugs Function
These medications replicate a natural hormone to reduce digestion speed, reduce hunger and increase feelings of fullness so people eat less.
Patients usually start to lose weight in the initial weeks of commencing the regular doses.
Research indicates patients may regain a significant portion within a year of halting the treatment, because their normal hunger come back.
Being overweight or obese raises your likelihood for contracting diseases, including diabetes, heart disease, stroke, and some cancers.
Excess weight affects individuals in every country and was responsible for over three and a half million fatalities worldwide in 2024, per the health agency.
